The state of serum lipids profiles in sub-clinical hypothyroidism: A review of the literature

Pakistan Journal of Biological Sciences

Volumn 13, Issue 11, 2010, Pages 556-562

  Mansourian, Azad Reza ^a  

^a GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hypothyroid; Lipid disorder; Sub clinical hypothyroid; Thyroid; Thyroid stimulating hormone; Thyroxin

Indexed keywords

EID: 77954440803     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2010.556.562     Document Type: Article

References (62)

1. Agdeppa, D., C. Macaron, T. Mallik and N.D. Schnuda, 1979. Plasma high density Lipoprotein cholesterol concentration in thyroid disease. J. Clin. Endocrinol. Metab., 49: 726-729.
2. Althaus, B.U., J.J. Staub, A.L. Ryff-DeLeche, A. Oberhansli and H. Staheline, 1998. B.LDL/HDL-changes in subclinical hypothyroidism: Possiblerisk factors for coronary heart disease. Clin. Endocrinol., 28: 157-163.
3. Arem, R., D.A. Escalante, N. Arem, J.D. Morrisett and W. Patsch, 1995. Effect of 1-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism with special reference to lipoprotein(a). Metabolism, 44: 1559-1563.
4. Ayala, A.R., M.D. Danese and P.W. Ladenson, 2000. When to treat mild hypothyroidism. Endocrinol. Metab. Clin. North Am., 29: 399-415.
5. Baloch, Z., P. Carayon, B. Conte-Devolx, L.M. Demers and U. Feldt-Rasmussen et al., 2003. Laboratory medicine practice guidelines: Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid, 13: 3-126.
6. Baskm, H.G., R.H. Cobin, D.S. Dmck, H. Gharib, M.M. Kaplan and R.L. Segal, 2002. American Association of Clinical Endocrinologist medical guidelines for the evaluation and treatment of hyperthyroidism and hyperthyroidism. Endor. Pract, 8: 457-469.
7. Bastenie, P.A., L. Vanhaelst and P. Neve, 1967. Coronary-artery disease in hypothyroidism. Lancet, 290: 1221-1222.
8. Bemben, D.A., R.M. Hamm, L. Morgan, P. Winn, A. Davis and E. Barton, 1994. Thyroid disease in the elderly, part 2: Predictability of subclinical hypothyroidism. J. Fam. Pract, 38: 583-588.
9. Bonger, U., H.R. Arntz, H. Peters and H. Schleusener, 1993. Subclinical hypothyroidism and hyperlipidemia: Indiscriminate 206 thyroxine treatment not justified. Acta Endocrinol, 28: 202-206.
10. Cabral, M.D., AJ.L. Costa, M. Santos and M. Vaisman, 2004. Lipid profile alterations in subclinical hypothyroidism: The endocrinologist. Endocrinologist, 14: 121-125.
11. Canaris, GJ, N.R Manowitz, G. Mayor and E.C. Ridgway, 2000. The Colorado thyroid disease prevalence study. Arch. Intern. Med., 160: 526-534.
12. Caraccio, N, E. Ferrannini and F. Monzani, 2002. Lipoprotein profile in subclinical hypothyroidism: Response to levothyrosine replacement, a randomized placebo-controlled study. J. Clin. Endocrinol. Metab., 87: 1538-1553.
13. Caron, P., C. Calazel, H. J. Parra, M. Hoff and J.P. Louvet, 1990. Decreased HDL cholesterol in subclinical hypothyroidism: The effortof L-thyroxine therapy. Clin. Endocrinol., 33: 519-523.
14. Cooper, D.S., R. Halpern, L.C. Wood, A.A. Levin and E.C.L. Ridgway, 1984. Thyroxine therapy in subclincal hypothyroidism: A double-blind, placebo-controlled trial. Ann. Intern. Med., 101: 18-24.
15. Cooper, D.S., 1998. Subclinical thyroid disease: A clinician's perspective. Ann. Intern. Med., 129: 135-138.
16. Cooper, D.S., 2001. Subclinical hypofhyroidiam. N. Engl. J. Wed., 345: 260-265.
17. Danese, M.D., N.R. Powe, C.T. Sawin and P.W. Ladenson-Jama, 1996. Screening for mild thyroid failure at the periodic examination: A decision and cost-effectiveness analysis. Am. Med. Assoc, 276: 285-292.
18. Danese, M.D., P.W. Landenson, C.L. Meinert and N.R. Powe, 2000. Effect of thyroxine therapy on serum lipoprotrin in patients with mild thyroid failure: A quantitative review of literature. J. Clin. Endocrinal. Metab., 85: 2993-3001.
19. De Bruin, T.W., H. van Barlingen, M. van Linde-Sibenius Trip, A.R. van Vuurst de Vries, M.J. Akveld and D.W. Erkelens, 1993. Lipoprotein(a). and apolipoprotein B plasma concentration in hypothyroid euthyroid and hyperthyroid subjects. J. Ciln. Endocrinol. Metatab., 76: 121-126.
20. Duntas, L.H., 2002. Thyroid disease and lipids. Thyroid, 12: 287-293.
21. Efstathiadou, Z., S. Bitsis, H.J. Milionis, A. Kukuvitis, E. Bairaktari, M. Elisaf and A. Tsatsoulis, 2001. Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial? Eur. J. Endocrinol., 145: 705-710.
22. Elder, J., A. McLelland, D.S. O'Reilly, C.J. Packard, J.J. Series and J. Shepherd, 1990. The relationship between serum cholesterol and serum thyrotropin, thyroxine and tri-iodothyronine concentrations in suspected hypothyroidism. Ann. Clin. Biochem., 27: 110-113.
23. Flower, P.S. and J. Swale, 1967. Premyxoedema and coronary-artery disease. Lancet, 1: 1077-1079.
24. Galesnu, C, N. Lisnic, R. Teslaru, L. Apostu and E. Zbranca, 2004. Lipid profile in a group of hypothyroid patients vs treated hypothyroid patients. Rev. Med. Chir. Soc. Med. Nat. Lasi., 108: 554-560.
25. Geul, K.W., I.L. van Sluisveld, D.E. Grobbee, R. Docter and A.M. de Bruyn et at., 1993. The importance of thyroid microsomal antibodies in the development of elevated serum TSH in middle-aged women: Associations with serum lipids. Clin. Endoorinol., 39: 275-280.
26. Hak, A.E., H.A. Pols and T.J. Visaer, 2000. Subclinical hypothyroidism is an independent risk fartor for arthreosclerosis and myocardial infarction in elderly women: The Rotterdam study. Ann. Intern. Med., 132: 270-278.
27. Hazzard, W.R. and E.L. Bierman, 1972. Aggravation of broad-disease (type 3 hyperlipoproteinemia) by hypothyroidism. Arch. Intern. Med., 130: 822-828.
28. Helfand, M. and C.C. Redfern, 1998. Screening for thyroid disease: An update. Ann. Intern. Med., 129: 144-158.
29. Hollowell, J.G., N.W. Staehling, W.D. Flanders, W.H. Harmon, E.W. Gunter, C.A. Spencer and L.E. Braverman, 2002. Serum TSH, T4 and thyroid autoantibody in United States population (1985-1994): National Health and Nutrition Examination Survey (NHANESM). J. Clin. Endocrinol. Metab., 87: 489-499.
30. Jung, C.H., K.C. Sung, H.S.S. Shin, F.J. Rhee and W.Y. Lee etal., 2003. Thyroid dysfunction and their relation to cardiovascular risk factors such as lipid profile, HSCRP and waist hip ratio in Korea. Korean J. Intern. Med., 18: 146-153.
31. Kahaly, G.J., 2000. Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid, 10: 665-679.
32. Kanaya, A.M., F. Harris, S. Volpato, E.J. Perez-Stable, T. Harris and D.C. Bauer, 2002. Association between thyroid dysfunction and total cholesterol level in an older biracial population: the health, aging and body composition study population: The health aging and body composition study. Arch. Intern. Med., 162: 773-779.
33. Kung, A.W.C., R.W.C. Pang E.D. Janus, 1995. Elevated serum lipoprotein(a) in subclinical hypothyroidism. Clin. Endocrinol., 43: 445-449.
34. Lindemann, R.D., D.S. Srhade, A. la Rur, LJ. Romero and H.C. Iiang etal, 1999. Subclinical hypothyroidism in a biethnic, urban community. J. Am. Geriatr. Soc, 47: 703-709.
35. Lindeman, R.D., LJ. Romero, D.S. Schade, S. Wayne, R.N. Baumgartner and PJ. Garry, 2003. Impact of subclinical hypothyroidism on serum total homocysteine concentrations, the prevalence of coronary heart disease (CHD) and CHD risk factors in the New Mexico Elder Health Survey. Thyroid, 13: 595-600.
36. Lithell, H., G. Boberg, K. Hellsing, S. Ljunghall, G. Lundqvist, B. Vessby and L. Wide, 1981. Serum lipoprotein and apolipoprotein concentrations and tissue lipoprotein-lipase activity in overt and subclinical hypothyroidism: The effect of substitution therapy. Eur. J. Clin. Invest., 11: 3-10.
37. Luboshitzky, R, A. Aviv, P. Herer and L. Lavie, 2002. Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid, 12: 421-425.
38. Mansourian, A.R., E.O. Ghaemi, A.R. Ahmadi, A. Saifi, A.V. Moradi and S. Bakhshandeh-Nosrat, 2007. A survey of urinary iodine concentration in South-east of Caspian Sea in Northern, Iran. Pak. J. Biol. Sci., 10: 2166-2171.
39. Mansourian, A.R., E. Ghaemi, A.R. Ahmadi, A. Marjani, A. Saifi and S. Bakhshandehnosrat, 2008. Serumlipid level alterations in sub clinical hypothyroid patients in Gor-gan (South East of Caspian Sea), J. Chinese Clin. Med., 3: 206-210.
40. Mansourian, A.R., A.R. Ahmadi, H.R. Mansourian, A. Saifi, A. Marjani, G.R. Veghan and E. Ghaemi, 2010. Maternal thyroid stimulating hormone levels during the first trimester of pregnancy at the south-east of the Caspian Sea In Iran. J. Clin. Diagnostic Res., http://www.jcdr.net/article_fulltext. asp?issn=0973-709x&year=2010&month=May&volume=&issue=&page=&id=719
41. Marjani, A., A.R. Mansourian, E.O. Ghaemi, A. Ahmadi and V. Khori, 2008. Lipid peroxidation in the serum of hypothyroid patients(In Gorgan-South East of Caspian Sea). Asian J. Cell Biol, 3: 47-50.
42. Meier, C, JJ. Staub, C.B. Roth, M. Guglielmetti and M. Kunz et al, 2001. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: A double blind, placebo-controlled trial (Basel Thyroid Study). J. Clin. Endocrinol. Metab., 86: 4860-4866.
43. Milionis, H.J., Z. Efstathiadou, A.D. Tselepis, E.T. Bairaktari, L.D. Tsironis, A. Tsatsoulis and M.S. Elisaf, 2003. Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: Effect of treatment with levothyroxine. Thyroid, 13: 365-369.
44. Miura, S., M. Litaka, H. Yoshimura, S. Kitahama and N. Fukasawa etal., 1994. Disturbed Lipidmetabolism in patients with subclinicalhypothyroidism: Effect of L-thyroxine therapy. Int. Med., 33: 413-417.
45. Muls, E., M. Rossenen, V. Blaton, E. Lesaffre, G. Lamberigts and P. de Moor, 1984. Serum lipids and apolipoproteins AI, All and B in primary hypothyroidism before and during treatment. Eur. J.Clin. Invest, 14: 12-15.
46. Nikkila, E. and M. Kekki, 1973. Plasma triglyceride metabolism in thyroid disease. J. Clin. Invest, 51: 2103-2114.
47. O'Brien, T., S.F. Dinneen, P.C. O'Brien and PJ. Palumbo, 1993. Hyperlipidemia in patients with primary and secondary hypo-thyroidism. Mayo Clin. Proc, 68: 860-866.
48. Parle, J.V., J.A. Franklyn, K.W. Cross, S.R. Jones and M.C. Sheppard, 1992. Circulating lipids and minor abnormalities of thyroid function. Clin. Endocrinol., 37: 411-414.
49. Pazos, F., J.J. Alvarez, J. Rubies-Prat, C. Varela and M.A. Lasuncion, 1995. Long term thyroid replacement therapy and levels of lipoprotein (a) and other lipoproteins. J. Clin. Endocrinol. Metab., 80: 562-566.
50. Pirich, C, M. Mullner and H. Sinzinger, 2000. Prevalance and relevance of thyroid dysfunction, in 1922 cholesterol screening participants. J. Clin. Epidemiol., 53: 623-629.
51. Roti, E., R Minelli, E. Gardim and L.E. Braverman, 1993. The use and misuse of thyroid hormone. Endocrine Rev., 14: 401-423.
52. Samuels, M.H., 1998. Subclinical thyroid disease in the elderly. Thyroid, 9: 80-80.
53. Shahmohamadi, F., A.R. Mansourian and H. Mansourian, 2008. Serum thyroid hormoe level in women in early pregnancy. J. Med. Sci., 8: 507-510.
54. Singer, P.A, D.S. Cooper, E.G. Levey, P.W. Ladenson and L.E. Braverman et al, 1995. Treatment guidelines for patients with hyperthyroidism and hyperthyroidism. JAMA., 273: 808-812.
55. Staub, J.J., B.U. Althaus, H. Engler, A.S. Ryff and P. Trabucco et al, 1992. Spectrum of subclinical and overt hypothyroidism: Effect on fhyrotropin prolactin and thyroid reserve and metabolic impact on peripheral target tissues. Am. J. Med., 92: 631-642.
56. Topliss, D.J. and C.J. Eastman, 2004. Diagnosis and management of hyperthyroidism and hypothyroidism. Med. J. Aust, 180: 186-194.
57. Tunbndge, W.M., D.C. Evered, R. Hall, D. Appleton and M. Brewis et al., 1977. Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure. Clin. Endocrinol. (Oxf)., 7: 495-508.
58. Tunbndge, W.M., D.C. Evered, R. Hall, D. Appleton and M. Brewis etal., 1985. The aspectrum of thyroid disease in a community: The Whickhum survey. Clin. Endocrinol, 7: 481-483.
59. Vala, B.S., 2001. Endocrinology and the Heart. In: Cardioloz, Carwford, M.H. and J.P. di Marco (Eds.). IstEdn., Mosby, London, pp: 8.4.1.
60. Vanderpump, M.P.J., J.A.O. Ahiquist, J.A. Franom and R.N. Clayton, 1996. Consensus statement for good practice in the management of hypothyroidism and hypothyroidism. Brit. Med. J., 313: 539-544.
61. Yildirimkaya, M., M. Ozata, K. Yilmaz, C. Kiline, M.A. Gundogen and T. Kutluay, 1996. Lipoprotein(a)concentration in subclinical hypothyroidism before and after levo-thyroxine therapy. Endocr. J., 43: 731-736.
62. Zulewski, H., B. Muller, P. Exer, A.R. Miserez and J.J. Staub, 1997. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J. Clin. Endocrinol. Metab., 82: 771-776.